Table 1. Characteristics of the patients and donors.

PBPC, peripheral blood progenitors cells.

G-CSF, granulocyte-colony stimulating factor (10 µg/kg/day); Cy-Cyclophosphamide (5 g/m²); Cy+VP-16 Cyclophosphamide (5 g/m²)+VP-16 (400 mg/m²).

ICE, Ifosfamide 5,000 mg/m² carboplatin AUC=5 (max. 800 mg); e, 100 mg/m².

DHAP, Cisplatin 100 mg/m²; cytarabine, 2,000 mg/m²; Dexamethasone 40 mg.